Century Therapeutics (IPSC) Other Non Operating Income (2020 - 2026)

Century Therapeutics (IPSC) has 7 years of Other Non Operating Income data on file, last reported at $20000.0 in Q1 2026.

• Other Non Operating Income for Q1 2026 came in at $20000.0, up 152.63% year-over-year; the trailing twelve-month figure through Mar 2026 was $333000.0 (up 8.82% YoY), and the FY2025 annual result was $275000.0, down 22.32% from the prior year.
• Other Non Operating Income retreated to $20000.0 in Q1 2026 per IPSC's latest filing, from $103000.0 in the prior quarter.
• Over five years, Other Non Operating Income peaked at $4.4 million in Q4 2022 and troughed at -$194000.0 in Q1 2023.
• A 5-year average of $272117.6 and a median of $11000.0 in 2024 frame the typical range for Other Non Operating Income.
• The sharpest annual moves came in 2022 and 2023: Other Non Operating Income soared 2593.82% in 2022, then slumped 3820.0% in 2023.
• A 5-year view of Other Non Operating Income shows it stood at $4.4 million in 2022, then sank by 100.34% to -$15000.0 in 2023, then surged by 806.67% to $106000.0 in 2024, then dropped by 2.83% to $103000.0 in 2025, then slumped by 80.58% to $20000.0 in 2026.
• Business Quant data shows IPSC's Other Non Operating Income at $20000.0 in Q1 2026, $103000.0 in Q4 2025, and $97000.0 in Q3 2025.